Related Experiment Video
Updated: Feb 5, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
[2-deoxyglucose inhibits angiogenesis of rheumatoid arthritis via activating AMPK pathway]
Ying Wang1, Yingmei Wei1, Xiu Cheng1
1Faculty of Pharmacy, Bengbu Medical College, Bengbu 233000, China.
Objective:
To observe the effects of 2-deoxyglucose inhibiting synovial pannus of adjuvant arthritis rats and to explore its potential mechanism of inhibiting angiogenesis by investigating proliferation, migration and matrigel tube formation assay in vitro.
Methods:
The effect of 2-DG on synovial pannus was evaluated by histopathology of HE staining; HUVEC proliferation was determined by CCK-8 method; migration of FLS were determined by transwell; In vitro matrigel tube formation assay was made for assessing tube number of HUVEC; p-AMPK and Bcl-2 were detected by Western blot assay; AMPK signaling pathway in HUVEC was inhibited by compound C, which is an inhibitor of AMPK activation.
Results:
2-DG (200 mg/kg) obviously decreased appearance of synovial pannus (P < 0.01); in vitro, 2-DG (0.5 mmol/L and/or 5 mmol/L) obviously inhibited proliferation, migration and tube number of HUVEC (P < 0.01 or P < 0.001), and its effects on HUVEC were reversed by using AMPK antagonist (Compound C); Western blot showed that 2-DG (5 mmol/L) increased expression of p-AMPK and decreased expression of Bcl-2 (P < 0.05).
Conclusions:
Activating AMPK pathway and decreasing expression of Bcl-2 may the potential mechanism by which 2-DG contributes to anti-angiogenesis and effects of inhibiting proliferation, migration and tube number of HUVEC.
Insights
2-deoxyglucose (2-DG) effectively inhibits synovial pannus in adjuvant arthritis rats. It also suppresses human umbilical vein endothelial cell (HUVEC) proliferation, migration, and tube formation by activating the AMPK pathway and reducing Bcl-2 expression.
Area of Science:
- Biomedical Science
- Pharmacology
- Cell Biology
Background:
- Adjuvant arthritis is characterized by synovial pannus formation.
- Angiogenesis plays a crucial role in the development of synovial pannus.
- Inhibiting angiogenesis is a potential therapeutic strategy for adjuvant arthritis.
Purpose of the Study:
- To investigate the anti-angiogenic effects of 2-deoxyglucose (2-DG) on synovial pannus in adjuvant arthritis rats.
- To explore the underlying mechanisms of 2-DG's anti-angiogenic activity, focusing on endothelial cell behavior and signaling pathways.
Main Methods:
- Histopathological analysis (HE staining) of synovial pannus in adjuvant arthritis rats treated with 2-DG.
- In vitro assays including CCK-8 for HUVEC proliferation, Transwell for FLS migration, and Matrigel assay for HUVEC tube formation.
- Western blot analysis to detect p-AMPK and Bcl-2 expression.
- Inhibition of the AMPK signaling pathway using Compound C.
Main Results:
- 2-DG treatment significantly reduced synovial pannus formation in vivo (P < 0.01).
- In vitro, 2-DG inhibited HUVEC proliferation, migration, and tube formation (P < 0.01 or P < 0.001).
- These anti-angiogenic effects were reversed by Compound C, indicating AMPK pathway involvement.
- 2-DG increased p-AMPK and decreased Bcl-2 expression in HUVECs (P < 0.05).
Conclusions:
- 2-deoxyglucose exhibits anti-angiogenic properties relevant to adjuvant arthritis.
- The mechanism involves the activation of the AMPK signaling pathway.
- Downregulation of Bcl-2 expression is associated with 2-DG's anti-angiogenic effects.
More Related Videos
09:31Generation of Induced-pluripotent Stem Cells Using Fibroblast-like Synoviocytes Isolated from Joints of Rheumatoid Arthritis Patients
Published on: October 16, 2016
06:31Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis
Published on: October 6, 2023
Related Concept Videos
Inhibition of Cdk Activity
Feedback Inhibition
Mechanism of Angiogenesis
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Enzyme Inhibition
Regulation of Angiogenesis and Blood Supply